Correlation of HER-2 Status With Estrogen and Progesterone Receptors and Histologic Features in 3,655 Invasive Breast Carcinomas
- 1 April 2005
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 123 (4) , 541-546
- https://doi.org/10.1309/ymj3-a83t-b39m-rut9
Abstract
We studied the inverse relationship between HER-2 and estrogen (ER) and progesterone (PR) receptors using HER-2 testing and correlated HER-2 status with histologic features in 3,655 unselected invasive breast carcinomas. Immunohistochemical analysis for ER, PR, and HER-2 and fluorescence in situ hybridization for HER-2 were performed. ER and PR expression were decreased significantly in HER-2+ tumors compared with HER-2– tumors (ER, 49.1% vs 78.17%; PR, 24.3% vs 53.13%). Even among HER-2+ tumors, the rate of ER or PR expression in high-grade tumors was significantly decreased compared with intermediate-grade tumors. HER-2 was positive in 10.87% of grade 2 and 27.84% of grade 3 ductal carcinomas and negative in all grade 1 ductal carcinomas. HER-2 overexpression or amplification essentially was limited to grades 2 and 3 ductal carcinomas and correlated inversely with ER or PR expression. Although ER or PR expression is decreased in HER-2+ tumors, a substantial proportion of them still express ER or PR.Keywords
This publication has 16 references indexed in Scilit:
- Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancerEuropean Journal of Histochemistry, 2009
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- Prognostic and predictive factors in breast cancerCancer Treatment Reviews, 2001
- High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 casesHistopathology, 2000
- Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patternsCancer, 1996
- C-ERBB-2 oncogens protein inIn situ and invasive lobular breast neoplasiaCancer, 1991
- correlation between histologic grade of malignancy and copy number of c-erbb-2 gene in breast carcinoma. A retrospective analysis of 176 casesCancer, 1990
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- QUANTITATIVE OESTRADIOL RECEPTOR VALUES IN PRIMARY BREAST CANCER AND RESPONSE OF METASTASES TO ENDOCRINE THERAPYThe Lancet, 1981
- Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancerPublished by Elsevier ,1980